Q712K3
Gene name |
UBE2R2 (CDC34B, UBC3B) |
Protein name |
Ubiquitin-conjugating enzyme E2 R2 |
Names |
E2 ubiquitin-conjugating enzyme R2, Ubiquitin carrier protein R2, Ubiquitin-conjugating enzyme E2-CDC34B, Ubiquitin-protein ligase R2 |
Species |
Homo sapiens (Human) |
KEGG Pathway |
hsa:54926 |
EC number |
2.3.2.23: Aminoacyltransferases |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
5 structures for Q712K3
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 6NYO | X-ray | 150 A | A | 1-202 | PDB |
| 8PQL | EM | 376 A | C | 1-238 | PDB |
| 8Q7R | EM | 371 A | C | 1-238 | PDB |
| 8R5H | EM | 344 A | C | 1-192 | PDB |
| AF-Q712K3-F1 | Predicted | AlphaFoldDB |
65 variants for Q712K3
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| TCGA novel | 16 | E>Q | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| TCGA novel | 46 | F>S | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
| rs767478191 | 60 | A>= | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA373223566 rs1249869746 |
60 | A>T | No |
ClinGen gnomAD |
|
|
rs926251179 COSM1231555 CA192534642 |
60 | A>V | large_intestine [Cosmic] | No |
ClinGen cosmic curated Ensembl |
|
rs750352043 CA5029415 |
61 | H>Q | No |
ClinGen ExAC gnomAD |
|
|
CA192534646 rs1056601087 |
61 | H>Y | No |
ClinGen Ensembl |
|
|
rs952222575 CA373223635 |
63 | K>I | No |
ClinGen TOPMed gnomAD |
|
|
CA192534647 rs952222575 |
63 | K>T | No |
ClinGen TOPMed gnomAD |
|
|
CA5029417 rs766028687 |
66 | I>T | No |
ClinGen ExAC gnomAD |
|
|
rs142075824 CA5029416 |
66 | I>V | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA373223702 rs1482314218 |
67 | D>E | No |
ClinGen TOPMed |
|
|
rs1207326879 CA373223819 |
75 | F>L | No |
ClinGen gnomAD |
|
|
CA373223897 rs1564000408 |
80 | K>R | No |
ClinGen Ensembl |
|
|
CA192534665 rs112637167 |
85 | N>H | No |
ClinGen Ensembl |
|
|
CA192534669 rs113299589 |
85 | N>T | No |
ClinGen Ensembl |
|
|
rs752304792 CA5029421 |
87 | Y>C | No |
ClinGen ExAC gnomAD |
|
|
rs1247979664 CA373224032 |
87 | Y>H | No |
ClinGen gnomAD |
|
|
CA192534675 rs113727596 |
88 | E>K | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen Ensembl NCI-TCGA |
| TCGA novel | 91 | D>Y | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1363142234 CA373225415 |
98 | H>R | No |
ClinGen gnomAD |
|
|
rs757997369 CA5029443 |
99 | P>L | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen ExAC NCI-TCGA gnomAD |
|
CA5029445 rs750997097 |
121 | R>K | No |
ClinGen ExAC |
|
|
CA373226882 rs1212018439 |
123 | I>N | No |
ClinGen TOPMed |
|
| TCGA novel | 129 | S>* | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA192552869 rs979918615 |
136 | T>P | No |
ClinGen Ensembl |
|
|
rs1343682995 CA373226983 |
138 | S>C | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA gnomAD |
|
CA373226980 rs1587485400 |
138 | S>P | No |
ClinGen Ensembl |
|
| TCGA novel | 139 | P>L | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA5029468 rs779184762 |
141 | N>S | No |
ClinGen ExAC gnomAD |
|
|
rs1468024826 CA373227030 |
146 | V>I | No |
ClinGen gnomAD |
|
|
rs1392032219 CA373227040 |
147 | M>T | No |
ClinGen gnomAD |
|
|
CA373227046 COSM1462095 rs1447755159 |
148 | F>L | large_intestine [Cosmic] | No |
ClinGen cosmic curated gnomAD |
|
rs200839853 CA192552899 |
153 | D>V | No |
ClinGen 1000Genomes |
|
|
rs776445334 CA5029474 |
154 | S>N | No |
ClinGen ExAC gnomAD |
|
|
CA5029475 rs745750000 |
157 | K>R | No |
ClinGen ExAC gnomAD |
|
|
rs769740820 CA5029476 |
158 | D>E | No |
ClinGen ExAC |
|
| TCGA novel | 163 | E>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA192557178 rs944112225 |
170 | S>L | No |
ClinGen TOPMed |
|
|
rs1315118319 CA373227587 |
170 | S>P | No |
ClinGen gnomAD |
|
|
CA5029499 rs749159569 |
172 | T>S | No |
ClinGen ExAC gnomAD |
|
|
rs773893146 CA5029501 |
175 | E>K | No |
ClinGen ExAC gnomAD |
|
|
rs771516938 CA5029503 |
177 | E>D | No |
ClinGen ExAC gnomAD |
|
|
rs772731336 CA5029504 |
180 | G>V | No |
ClinGen ExAC gnomAD |
|
| TCGA novel | 183 | V>A | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA5029505 rs760157116 |
185 | T>K | No |
ClinGen ExAC gnomAD |
|
|
CA373227703 rs1181178013 |
188 | A>V | Variant assessed as Somatic; impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed |
| TCGA novel | 191 | C>F | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs1202336903 CA373227751 |
195 | K>E | No |
ClinGen TOPMed |
|
|
rs763320246 CA5029508 |
199 | N>S | No |
ClinGen ExAC gnomAD |
|
|
COSM455857 CA192557252 rs372565481 |
201 | N>K | Variant assessed as Somatic; impact. breast [NCI-TCGA, Cosmic] | No |
ClinGen cosmic curated ESP ExAC NCI-TCGA gnomAD |
| TCGA novel | 202 | S>I | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
rs145589627 CA5029511 |
204 | D>N | No |
ClinGen ESP ExAC |
|
|
CA373227839 rs1320272305 COSM291309 |
208 | D>N | large_intestine Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] | No |
ClinGen cosmic curated NCI-TCGA TOPMed |
|
CA373227860 rs1200306189 |
210 | L>F | No |
ClinGen Ensembl |
|
|
CA5029517 rs143620598 |
214 | D>N | No |
ClinGen ESP ExAC TOPMed gnomAD |
|
|
CA373227914 rs1564008880 |
217 | D>E | No |
ClinGen Ensembl |
|
|
rs778731566 CA5029520 |
219 | D>E | No |
ClinGen ExAC TOPMed |
|
|
rs1026908813 CA192557356 |
225 | A>V | No |
ClinGen TOPMed |
|
|
CA5029522 rs771807900 |
226 | D>N | No |
ClinGen ExAC TOPMed gnomAD |
|
|
CA373227993 rs1564008900 |
228 | Y>H | No |
ClinGen Ensembl |
|
|
rs867080039 CA192557398 |
234 | G>E | No |
ClinGen Ensembl |
|
|
rs1455175817 CA373228039 |
234 | G>R | No |
ClinGen gnomAD |
|
| TCGA novel | 236 | E>G | Variant assessed as Somatic; impact. [NCI-TCGA] | No | NCI-TCGA |
|
CA192557402 rs960341662 |
238 | S>L | Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] | No |
ClinGen NCI-TCGA TOPMed gnomAD |
No associated diseases with Q712K3
Functions
| Description | ||
|---|---|---|
| EC Number | 2.3.2.23 | Aminoacyltransferases |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
1 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
3 GO annotations of molecular function
| Name | Definition |
|---|---|
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| ubiquitin conjugating enzyme activity | Isoenergetic transfer of ubiquitin from one protein to another via the reaction X-ubiquitin + Y -> Y-ubiquitin + X, where both the X-ubiquitin and Y-ubiquitin linkages are thioester bonds between the C-terminal glycine of ubiquitin and a sulfhydryl side group of a cysteine residue. |
| ubiquitin-protein transferase activity | Catalysis of the transfer of ubiquitin from one protein to another via the reaction X-Ub + Y --> Y-Ub + X, where both X-Ub and Y-Ub are covalent linkages. |
4 GO annotations of biological process
| Name | Definition |
|---|---|
| protein K48-linked ubiquitination | A protein ubiquitination process in which a polymer of ubiquitin, formed by linkages between lysine residues at position 48 of the ubiquitin monomers, is added to a protein. K48-linked ubiquitination targets the substrate protein for degradation. |
| protein monoubiquitination | Addition of a single ubiquitin group to a protein. |
| protein polyubiquitination | Addition of multiple ubiquitin groups to a protein, forming a ubiquitin chain. |
| ubiquitin-dependent protein catabolic process | The chemical reactions and pathways resulting in the breakdown of a protein or peptide by hydrolysis of its peptide bonds, initiated by the covalent attachment of a ubiquitin group, or multiple ubiquitin groups, to the protein. |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAQQQMTSSQ | KALMLELKSL | QEEPVEGFRI | TLVDESDLYN | WEVAIFGPPN | TLYEGGYFKA |
| 70 | 80 | 90 | 100 | 110 | 120 |
| HIKFPIDYPY | SPPTFRFLTK | MWHPNIYENG | DVCISILHPP | VDDPQSGELP | SERWNPTQNV |
| 130 | 140 | 150 | 160 | 170 | 180 |
| RTILLSVISL | LNEPNTFSPA | NVDASVMFRK | WRDSKGKDKE | YAEIIRKQVS | ATKAEAEKDG |
| 190 | 200 | 210 | 220 | 230 | |
| VKVPTTLAEY | CIKTKVPSND | NSSDLLYDDL | YDDDIDDEDE | EEEDADCYDD | DDSGNEES |